Pattern of multiple human papillomavirus infection and type competition: An analysis in healthy Chinese women aged 18

Pattern of multiple human papillomavirus infection and type competition: An analysis in healthy Chinese women aged 18–45 years

Published:2024-04-15 Issue:1 Volume:20 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Su Yingying¹²,Zheng Tingquan¹²,Bi Zhaofeng¹²,Jia Xinhua¹²³,Li Yufei¹²³,Kuang Xuefeng¹²³,Yang Yuan¹²³,Chen Qi¹²,Lin Hongyan¹²,Huang Yue¹²,Huang Shoujie¹²,Qiao Youlin³,Wu Ting¹²,Zhang Jun¹²,Xia Ningshao¹²

Affiliation:

1. State Key Laboratory of Vaccines for Infectious Diseases, Xiang an Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, China

2. National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration in Vaccine Research, NMPA Key Laboratory for Research and Evaluation of Infectious Disease Diagnostic Technology, Xiamen University, Xiamen, China

3. National Cancer Center, National Center for Cancer Clinical Research, The Cancer Institute, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Fujian Province

CAMS Innovation Fund for Medical Sciences of China

Fundamental Research Funds for the Central Universities

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2024.2334474

Reference32 articles.

1. Human Papillomavirus Laboratory Testing: the Changing Paradigm

2. EUROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection

3. Worldwide burden of cancer attributable to HPV by site, country and HPV type

4. Present status of human papillomavirus vaccine development and implementation

5. Human papillomavirus vaccines: WHO position paper, May 2017;World Health Organization;Wkly Epidemiol Rec,2017